Sepsis during short bowel syndrome hospitalizations: Identifying trends, disparities, and clinical outcomes in the United States

Table 5 Gender distribution of elixhauser co-morbidities for septic short bowel syndrome hospitalizations in the United States from 2005-2014

Elixhauser co-morbidity	Male	Female	P value
Acquired immunodeficiency syndrome	0.3	0.1	< 0.0001
Alcohol abuse	2.9	1.0	< 0.0001
Deficiency anemias	36.8	39.7	< 0.0001
Rheumatic disorders	2.0	5.1	< 0.0001
Chronic blood loss anemia	1.9	2.1	0.0800
Congestive heart failure	10.7	10.8	0.9000
Chronic pulmonary disease	16.7	19.0	< 0.0001
Coagulopathy	16.8	15.0	< 0.0001
Depression	12.4	18.1	< 0.0001
Uncomplicated diabetes	12.6	11.6	0.0010
Diabetes with chronic complications	3.9	2.7	< 0.0001
Drug abuse	5.1	4.5	0.0010
Hypertension	33.6	32.1	0.0010
Hypothyroidism	6.0	14.9	< 0.0001
Liver disease	7.4	5.3	< 0.0001
Lymphoma	1.4	0.9	< 0.0001
Fluid and electrolyte disorders	56.6	57.9	0.0030
Metastatic cancer	4.9	4.4	0.0020
Neurological disorders	7.0	8.8	< 0.0001
Obesity	3.8	6.4	< 0.0001
Paralysis	3.5	2.1	< 0.0001
Peripheral vascular disorders	8.1	5.9	< 0.0001
Psychiatric disorder	4.7	6.3	< 0.0001
Pulmonary circulation disorders	4.2	3.8	0.0400
Renal failure	26.3	18.8	< 0.0001
Solid tumor without metastasis	2.6	2.7	0.5900
Peptic ulcer disease excluding bleeding	0.0	0.1	< 0.0001
Valvular disease	5.2	4.7	0.0100
Weight loss	39.1	40.9	< 0.0001